Per Reuters, Deutsche Bank AG DB has come up with the sale of unwanted assets worth $50 billion to Goldman Sachs GS, continuing with its overhauling moves for reviving profitability. The move is part of the bank’s overhaul of emerging-market debt holdings.
Part of the company’s restructuring moves included creation of a new Capital Release Unit, also called a bad bank. This ensures smooth winding down of assets related to businesses from which the bank plans to exit in the near term. Therefore, the latest move of vending assets to Goldman was included in the series of winding down of such assets.
Notably, the bad bank holds assets worth 177 billion euros ($195 billion) in leverage exposure as of Sep 30, 2019. The bank targets to reduce the exposure to 119 billion euros by the end of this year. The unit holds mainly derivatives and emerging-market debt.
Per Deutsche Bank, portions of equity derivatives have been sold in three auctions. Further, the bank’s plans include selling off more complex equity derivatives over a couple of years.
“DBK’s structural challenges, as we see them, fall into three categories: the absence of a high-return platform, elevated funding costs and uncertainty around the scope of its IB business,” Goldman Sachs said in a statement on Deutsche's restructuring efforts.
Deutsche Bank has also entered into a deal with BNP Paribas SA BNPQY this September, per which the former will transfer its prime brokerage business to the latter. The French bank will service Deutsche Bank’s Global Prime Finance and Electronic Equities clients.
However, per the agreement, the platform will remain under the German bank till the migration of clients to BNP Paribas is complete. Moreover, amount of assets, staff and technology to be moved from Deutsche Bank to BNP Paribas are yet to be disclosed as the transition will take place in several stages.
Though Deutsche Bank’s restructuring efforts, including cost-saving measures, look encouraging, it is difficult to determine how much the bank will gain, considering the prevalent headwinds. Furthermore, dismal revenue performance is another concern.
Deutsche Bank currently carries a Zacks Rank #4 (Sell).
Shares of Deutsche Bank have lost around 9.7% on the NYSE, year to date, as against the industry’s growth of 3.8%.
A Stock to Consider
KB Financial Group Inc KB has been witnessing upward estimate revisions for the past 60 days, with the company’s shares appreciating nearly 4% on the NYSE, in six months’ time. It sports a Zacks Rank of 1 (Strong Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BNP Paribas SA (BNPQY) : Free Stock Analysis Report
Deutsche Bank Aktiengesellschaft (DB) : Free Stock Analysis Report
KB Financial Group Inc (KB) : Free Stock Analysis Report
The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research